Preclinical pharmacokinetics, pharmacodynamics, tissue distribution, and tumor penetration of anti-PD-L1 monoclonal antibody, an immune checkpoint inhibitor-Reference-Cited by-同舟云学术

Preclinical pharmacokinetics, pharmacodynamics, tissue distribution, and tumor penetration of anti-PD-L1 monoclonal antibody, an immune checkpoint inhibitor

Published:2016-02-26 Issue:3 Volume:8 Page:593-603
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Deng Rong,Bumbaca Daniela,Pastuskovas Cinthia V.,Boswell C. Andrew,West David,Cowan Kyra J.,Chiu Henry,McBride Jacqueline,Johnson Clarissa,Xin Yan,Koeppen Hartmut,Leabman Maya,Iyer Suhasini

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/19420862.2015.1136043

Reference28 articles.

1. Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up

2. Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma

3. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

4. Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy

5. PD-1 and Its Ligands in Tolerance and Immunity

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translate Pharmacokinetics of PD-1/PD-L1 Monoclonal Antibodies from Cynomolgus Monkey to Human: Comparison of Different Approaches;Journal of Pharmaceutical Sciences;2024-09

2. An Evidence-Based Rationale for Dose De-escalation of Subcutaneous Atezolizumab;Targeted Oncology;2024-07-31

3. Comparison of dose selection based on target engagement versus inhibition of receptor–ligand interaction for checkpoint inhibitors;CPT: Pharmacometrics & Systems Pharmacology;2024-05-24

4. Unveiling FDA-Approved Drugs and Formulations in the Management of Bladder Cancer: A Review;Current Pharmaceutical Biotechnology;2024-05-23

5. Dual neutrophil subsets exacerbate or suppress inflammation in tuberculosis via IL-1β or PD-L1;Life Science Alliance;2024-05-21